Hirohashi S, Shimosato Y, Ino Y, Kishi K
J Natl Cancer Inst. 1982 Sep;69(3):565-8.
The distribution of hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) in surgically removed liver cell carcinomas of 60 Japanese patients was studied by an immunohistochemical method. HBsAg was localized in the cytoplasm, and HBcAg was mainly in the nuclei of normal-appearing liver cells, dysplastic liver cells, and tumor cells. In some instances both HBsAg and HBcAg were contained in the tumor cells and liver cells. HBsAg was found in the nontumorous liver tissue of 30 patients (50%); nine of the HBsAg-containing nontumorous livers also contained HBcAg. HBsAg and/or HBcAg was detected in tumor cells in 7 (23%) of 30 cases with HBsAg-positive liver diseases.
采用免疫组织化学方法研究了60例日本患者手术切除的肝细胞癌中乙肝表面抗原(HBsAg)和核心抗原(HBcAg)的分布情况。HBsAg定位于细胞质中,而HBcAg主要存在于外观正常的肝细胞、发育异常的肝细胞及肿瘤细胞的细胞核中。在某些情况下,肿瘤细胞和肝细胞中同时含有HBsAg和HBcAg。在30例患者(50%)的非肿瘤性肝组织中发现了HBsAg;9例含有HBsAg的非肿瘤性肝脏也含有HBcAg。在30例HBsAg阳性肝病患者中,7例(23%)的肿瘤细胞中检测到了HBsAg和/或HBcAg。